FdaApplication
ANDA 217829
Identifiers
- fda_app_no: ANDA217829
Properties
| Property | Value |
|---|---|
| applicant_name | INVENTIA HEALTHCARE LIMITED |
| application_type | ANDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | SITAGLIPTIN, METFORMIN HYDROCHLORIDE | 100MG | TABLET, EXTENDED RELEASE |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | SITAGLIPTIN, METFORMIN HYDROCHLORIDE | 500MG | TABLET, EXTENDED RELEASE |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | SITAGLIPTIN, METFORMIN HYDROCHLORIDE | 50MG | TABLET, EXTENDED RELEASE |
3 products